Contagion Editorial Team

The Aptima HIV-1 Quant Dx assay is the first in the US to be able to make such a claim.

This guidance comes less than 24 hours after FDA grants an EUA for its use combined with baricitinib.

Bamlanivimab should be administered as soon as possible after a positive test, and within 10 days of developing symptoms, Eli Lilly said.

In a survey, a panel of experts sees the American response as problematic and weighs in on universal masking.

This action comes less than 24 hours after the J&J vaccine was paused.

As concerns are raised about prospective vaccines and their safety and efficacy, infectious disease experts offer support and insights about the development process.

Shionogi announces approval of cefiderocol for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.

Join us tomorrow for an informative discussion on CDC guidance and insights from medical experts on navigating a way back to in-school learning.

A study suggests that both have similar cycle thresholds but the virus lays dormat in an overwhelming majority of asymptomatic patients.

MJH Life Sciences is presenting a webinar today on this important topic.

A discussion between providers on 3 studies related to the antiviral.

Gregory Felzien, MD, AAHIVS, discusses prevention beyond PrEP and creating a safe environment for patients with HIV.